Mutant DNA polymerases and methods of use

• US 20060223067A1
• Filed: 03/31/2005
• Published: 10/05/2006
• Est. Priority Date: 03/31/2005
• Status: Abandoned Application

• Current Assignee: Applied Biosystems LLC (Thermo Fisher Scientific Incorporated)
• Original Assignee: Applied Biosystems LLC (Thermo Fisher Scientific Incorporated)
• Inventors: Vatta, Paolo, Spurgeon, Sandra L., Brandis, John W., Bolchakova, Elena V.
• Application Number:
  US11/095,042
• Publication Number:
  US 20060223067A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12N 9/1252 DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
• CPC Class Codes: C12Y 207/07007 DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase

Abstract

The present invention provides mutant DNA polymerases, polynucleotides encoding the polymerases, cassettes and vectors including such polynucleotides, and cells containing the polymerases, polynucleotides, cassettes, and/or vectors of the invention. The present invention also provides methods for synthesizing polynucleotides and kits including a DNA polymerase of the invention.

Claims

1. A mutant DNA polymerase comprising an Asn residue at amino acid 543 and a 5′

-3′

exonuclease activity reducing mutation, wherein the positions of amino acids of the mutant DNA polymerase are defined with respect to Taq DNA polymerase.

2. The mutant polymerase of claim 1, wherein the 5′

-3′

exonuclease activity reducing mutation is an N-terminal deletion.

3. The mutant polymerase of claim 1, wherein the 5′

-3′

exonuclease activity reducing mutation is an Asp residue at amino acid 46.

4. The mutant polymerase of claim 1, further comprising a Tyr residue at amino acid 667.

5. The mutant polymerase of claim 1 that is a thermostable DNA polymerase.

6. The mutant polymerase of claim 1 that is a mutant Taq DNA polymerase.

7. The mutant polymerase of claim 1 that is a thermostable mutant Taq DNA polymerase.

8. The mutant polymerase of claim 1 that comprises SEQ ID NO:

3 or SEQ ID NO;

5.

9. A polynucleotide comprising a sequence encoding the polymerase of claim 1.

10. A polynucleotide comprising a sequence encoding the polymerase of claim 4.

11. A polynucleotide comprising a sequence encoding the polymerase of claim 8.

12. The polynucleotide of claim 11 that comprises SEQ ID NO:

4 or SEQ ID NO;

6.

13. A vector comprising the polynucleotide of claim 9.

14. A vector comprising the polynucleotide of claim 10.

15. A vector comprising the polynucleotide of claim 11.

16. The vector of claim 13, further comprising a promoter operably linked to the polynucleotide.

17. The vector of claim 14, further comprising a promoter operably linked to the polynucleotide.

18. The vector of claim 15, further comprising a promoter operably linked to the polynucleotide.

19. A cell comprising the DNA polymerase of claim 1.

20. A cell comprising the polynucleotide of claim 9.

21. A cell comprising the vector of claim 13.

22. A method for synthesizing a polynucleotide in a reaction, comprising contacting the mutant polymerase of claim 1 with a primed template and nucleotides.

23. The method of claim 22, wherein the reaction is a chain termination sequencing reaction.

24. The method of claim 22, wherein the reaction is a polymerase chain reaction.

25. The method of claim 22, wherein the nucleotides comprise labeled nucleotides.

26. The method of claim 25, wherein the labeled nucleotides are fluorescently labeled nucleotides.

27. A kit comprising packaging material and the mutant polymerase of claim 1.

28. The kit of claim 27, further comprising labeled nucleotides.

29. The kit of claim 28, wherein the labeled nucleotides are fluorescently labeled nucleotides.

30. The kit of claim 27, further comprising unlabeled nucleotides.

31. The kit of claim 27, further comprising at least one primer.